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Abstract 
The global coronavirus disease 2019 (COVID-19) pandemic appears 
to have some streaks of severity in pediatrics. These streaks include 
variable signs of respiratory distress, a new entity called multi-
system inflammatory syndrome, and some evidences of neurological 
symptoms involving both central and peripheral nervous systems. 
Here, we described the first pediatric patient with COVID-19 who 
presented with acute transverse myelitis. An 11-year-old otherwise 
healthy girl presented to our clinic with acute onset of lower limbs 
paresis, urinary and fecal retention, alongside epigastric pain, and 
fever for 3 days. A neurological examination revealed a severe flaccid 
paraplegia in her lower limbs associated with a sensory level at T5. She 
was evaluated systematically for all probable causes of her symptoms, 
and finally, due to having a positive nasopharyngeal PCR test, she 
was considered to suffer from post-COVID-19 transverse myelitis. 
She underwent intravenous-immunoglobulin, methylprednisolone 
pulse, and other supportive cares without obvious results. Therefore, 
she underwent seven sessions of plasma exchange with little effects 
on muscle strength. The focal inflammation and injury of the spinal 
cord, otherwise known as transverse myelitis, have a wide array of 
potential etiologies. Transverse myelitis has been well documented to 
be the result of viral and bacterial infections. We believe our patient 
was not involved in a cytokine storm status due to good CRP, IL-6 
and Ferritin levels. Albeit, we cannot certainly consider the patient to 
have a direct viral impact or involved in a late immunity process. To 
our knowledge, this is the first report of TM in the field of pediatrics 
occurred after COVID-19. Thus, this is critical to note that children 
can present with some severe types of COVID-19. 
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Introduction
The global COVID-19 pandemic initially appeared 
to have milder courses in pediatrics. Since the 
last few weeks, there have been some streaks of 
severity in pediatric age reports, characterized 
by persistent fever, shock, myocarditis, and 
variable signs of a new entity called multi-system 
inflammatory syndrome (MIS-C) (1). Moreover, 
children with COVID-19-related MIS-C may 
experience neurological symptoms that involve 
both the central and peripheral nervous systems 
(CNS and PNS). In a case series of four pediatric 
patients with COVID-19 and neurological-related 
symptoms, encephalopathy, headache, brain 
stem and cerebellar signs, muscle weakness, and 
reduced reflexes were reported. All the patients had 
signal changes in the splenium of corpus callosum 
on neuroimaging in the absence of respiratory 
symptoms (2).
Since severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2)enters cells via 
the angiotensin-converting enzyme 2 (ACE-
2) receptor, and given that ACE-2 is expressed 
in both neurons and glial cells, a direct viral 
invasion of CNS may be a probable mechanism 
for neurological manifestations of COVID-19 
(3). However, only vascular cells and not neurons 
express ACE-2 in the brain; thus this potentially 
contributes to dissemination of virus into the 
brain by blood circulation (4). Albeit, an immune-
mediated neuronal syndrome has been recently 
proposed in some adult neurological reports 
(5). Here, we reported an 11-year-old girl who 
presented with new-onset neurological symptoms 
and neurological imaging findings identic with the 
diagnosis of acute transverse myelitis associated 
with COVID-19.
Case report
An 11-year-old otherwise healthy girl presented 
to our clinic with acute onset of lower limbs 
paresis, weakness, and urinary and fecal retention. 
She had also experienced epigastric pain and 
fever alongside her neurological symptoms for 3 
days. She had no history of other respiratory and 
gastrointestinal manifestations, previous medical 
illnesses, and medication consumption. At the time 
of admission, a neurological examination revealed 
a severe flaccid paraplegia in proximal of her 
lower limbs associated with a positive Lhermitte’s 
sign (electric shock-like sensation down the back 
triggered by forward bending of head), and a 
sensory level at T5. The upper limb force was near 
normal, and the lower limb force was 0 of 5. The 
Babinski’s sign had a natural response bilaterally. 
Moreover, deep tendon reflexes and the abdominal 
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consciousness, cognition, and cranial nerves was 
unaffected, and the bulbar sign was intact. The 
patient underwent the Foley catheter insertion 
procedure due to urinary retention, and she was 
evaluated systematically for all probable causes 
of her dilemma. Initial labs revealed a positive 
nasopharyngeal swab for SARS-CoV-2. The 
laboratory results showed a normal white blood 
cell count of 7.7^3/UL (4.0-10.0^3/UL), with 70% 
neutrophil and 26% lymphocyte. Hemoglobin, 
MCV, and platelet count were 11.5 gr/dl (12-15.5), 
76.5 fL (80-100), and 350^3/mL (150-450^3/
mL), respectively. C-reactive protein (CRP) was 
in normal range (1mg/L), while the erythrocyte 
sediment rate was minimally higher (24 mm/h) 
than normal (<12). No obvious changes were 
detected in electrolytes. The interleukine-6 level 
with the ELISA method was 12.8 pg/ml (14±6). 
D-dimer, coagulation profile PT (12 sec), PTT 
(32 sec), and INR (1.0) were all in normal ranges. 
SGOT, SGPT, and creatinine were 51 U/L, 17 U/L, 
and 0.4 mg/dl, respectively, and they were all in 
normal ranges. Certain phosphokinase was 3144 
U/L (24-170), and lactate dehydrogenase was 368 
(<580). The patient was evaluated serologically 
for some other potential viruses including 
EBV, CMV as well as bacteria (mycoplasma 
pneumonia), and the results were negative. The 
auto-immune rheumatological screening revealed 
negative results regarding anti-nuclear antibody, 
complement level, anti-cytoplasmic antibodies, 
angiotensin converting enzyme, rheumatoid factor, 
and anti-phospholipid antibodies. Although, the 
cerebrospinal fluid (CSF) had no obvious finding 
in analysis and culture, antibodies and viral 
PCR of CSF fluid were not performed during 
hospitalization. In electromyoneurography, F and 
H responses were unobtainable in the patient’s 
lower limbs. Echocardiography showed PFO 
(5-6 mm) without any evidence of embolism or 
functional effects. The chest x-ray was normal 
with no evidence of consolidation, cardiomegaly, 
and pleural effusion. A Gadolinium-enhanced 
magnetic resonance imaging of the brain and 
whole spine was performed, revealing no changes 
in the brain but a high signal intensity at T3-
T9 segments of the spinal cord associated with 
spinal cord swelling at T3-T6 segments and a 
central high signal area in the both halves of the 
spinal cord (Fig 1). Moreover, a post-contrast 
T1 weighted image showed mild heterogeneous 
patchy enhancement in the involved areas (Fig. 
2). The patient was evaluated systematically for 
all probable causes of her symptoms, and finally, 
due to having a positive nasopharyngeal PCR test, 
she was considered to suffer from post-COVID-19 
coronavirus transverse myelitis. She was treated 
with intravenous-immunoglobulin 0.4 g/Kg/day 
for 5 days, pulse of methylprednisolone 30 mg/
Kg for 3 days, and other supportive cares without 
obvious results. Therefore, she underwent seven 
sessions of plasma exchange, which only had 
slight effects on her lower limb muscle strength on 
day 16. 
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Fig 1. (A) The sagittal T2 weighted image of the thoracic spinal cord showing high signal intensity at T3-T9 segments of the spinal cord associated 
with spinal cord swelling at T3-T6 segments. (B) The axial T2 weighted image of thoracic spine showing spinal cord swelling and a central high signal 
area observed in the both levels of the spinal cord.
Fig 2. The sagittal (A) and axial (B) post-contrast T1 weighted image showing mild heterogeneous patchy enhancement in the involved area
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Discussion
The focal inflammation and injury of the spinal 
cord, otherwise known as transverse myelitis, have 
a wide array of potential etiologies. Transverse 
myelitis has been well documented to be the 
result of viral and bacterial infections. It can also 
be the first sign of neurologic conditions such as 
neuromyelitis optica and multiple sclerosis, or can 
be associated with some immune system disorders 
such as lupus or sarcoidosis (6). However, near 
60% of cases may remain idiopathic, suggesting 
that exact pathophysiology of the disease is unclear 
and may vary by etiology (7). Previous reports 
suggested that certain coronavirus genotypes 
including SARS-CoV in 2003 had neurotropic 
properties and may cause encephalomyelitis, 
Guillain-Barre, seizure, and loss of neurofunctional 
status (8). The first case of SARS-CoV-2 causing 
acute myelitis was published on March, 2020, from 
Wuhan, China, which was followed by a series of 
universal reports (3, 4, 6, and 8). Nevertheless, to 
our knowledge, this is the first report of TM in 
the field of pediatrics occurring after COVID-19. 
Thus, it should be noted that children can present 
with some severe types of COVID-19. 
Zhao and colleagues reported an association 
between COVID-19 and Guillain-Barre syndrome 
where neurological symptoms occurred without 
any preceding respiratory symptoms, suggesting a 
para-infectious process. It is still unclear whether 
TM occurs as a result of a direct impact of viral 
infection or as an autoimmune phenomenon. 
Moreover, it is still unclear whether the virus impacts 
vascular cells or disseminates into the nervous 
system via olfactory bulb when acting directly (4). 
Immune damage and cytokines by inflammatory 
storms at the early stage of SARS-CoV-2 infection 
might explain why the spinal cord is implicated at 
this setting (3). Furthermore, in advanced stages of 
the disease, neurological findings could be due to 
the effect of hypoxia sequels as well as respiratory 
and metabolic acidosis (4). However, the precise 
mechanism of the disease is unclear, and like in 
most post-infectious TM, an immune-mediated 
pathogenesis may be involved (8). We believe our 
patient was not involved in a cytokine storm status 
due to good CRP, IL-6 and Ferritin levels. Albeit, 
we cannot certainly consider whether the patient 
had a direct viral neurological impact or a delayed 
immunity phenomenon were happened, just like 
what happens in multi system inflammatory of 
childhood (MIS-C). We do not have PCR from 
CSF or some auto-antibodies as complementary 
parameters, and this appears to be the first pediatric 
post-coronavirus TM report. The patient’s medical 
file could be further investigated for NOM and 
other possibilities that we could not exclude despite 
our comprehensive systematic evaluation.
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